logo_hcam

Revista Médica Científica CAMbios

Periodicidad semestral: flujo continuo.

ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)

Ver PDF (Spanish)

Keywords

Mortality
Morbidity
Anesthesia, Cardiac Procedures
Hypnosis
Amnesia
Relaxation

How to Cite

1.
Morbility in cardiac anesthesia in the Carlos Andrade Marin Hospital during the year 2013. Cambios rev. méd. [Internet]. 2019 Jun. 27 [cited 2025 Nov. 21];14(25):32-7. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/236

Abstract

Introduction: general anesthesia in cardiovascular surgery is based not only on hypnosis, amnesia, neuromuscular blockade and analgesia; but must provide proper oxygenation, tissue perfusion, neurovegetative protection, acid base regulation, treat and prevent coagulopathy, thermic control, myocardic preserve, neurologic, renal and respiratory functions in order to keep homeostasis. Materials and methods: in this longitudinal descriptive observational trial, 114 patients who underwent cardiac surgery under general anesthesia were followed for 6 months. The median age of these patients was 55 with 26.32% morbidity and 17.54% mortality. Results: the most frequent surgeries were valvulopathies (52%) being the most common aortic stenosis; in second place congenital cardiopathies (24.67%), mainly trial communication, interventricular communication and patent ductus arteriosus. The two main co-morbilities were arterial hypertension (39%) and diabetes mellitus II (16%). 84% of patients had an ejection fraction of 55% and those with NYHA functional class III and IV had more risk of mortality OR 3.2 (p<0.05). 37.73% of patients received beta blockers before surgery with a protective effect OR 0.8 (p:<0.05). Conclusions: the time of extracorporeal circulation (EC) was less than 120 minutes in 23.32%, lengthier time of CEC showed a risk factor OR: 7 (p:<0.05). 25% of patients needed vasoactive and inotropic support. Only epinephrine reached statistical significance as a risk factor, nevertheless it could be because the number of patients that received this therapy was relatively small. All the groups, except nitroprussiade, had an OR>1. 85% of patients required transfusion with an OR 6.82 (p:<0.05) for postoperatory complications such as infection and bleeding.

Ver PDF (Spanish)

References

Organización Mundial de la Salud. Informe sobre la situación mundial de las enfermedades no transmisibles 2010. Resumen de orientación [citado 16 enero 2014]. Disponible en: http://www. who.int/nmh/publications/ncd_report 2010/es/

Instituto Nacional de Estadística y Censos (INEC) de 2010, disponible en www.ecuadorencifras.gob.ec

Hensley, Frederick A.; Martin, Donald E.; Gravlee, Glenn P. Practical Approach to Cardiac Anesthesia, The Cardiac Surgical Patient, Lippincott Williams & Wilkins, 4th Edition 2008

Ferenz C, Rubin JD, MC Carter RJ, Cardiac and non cardiac malformations, observation in population-basedstudy, Tetralogy, 1987; 35: 367-78

Nora JJ, Wolf RR, Recurencerisk in the family. The child with congenital heart desease after surgery, Mount kisko: futura; 1976, p 451-60

Boneva RS, Botto LD infant mortality and congenital anomalies from 1950 to 1994: an international perspective JECH 2000; 54: 660-6

Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update on Perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Card 2002;39:542-553

Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003;289:2560-2572

Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354;449-461

Girish M, Trayner E, Dammann O, et al. Symptom-limited stair climbing as a predictor of postoperative cardiopulmonary complications after high-risk surgery. Chest 2001;120:1147-1151

Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta- blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-361

Wyte SR:Cardioplegic solution: What combination of additives? In Utley J,: Pathophysiology and Techniques of cardiopulmonary bypass, 1° ed. Baltimore, Williams &Wilkins, 1982, pp 138-150

José J. Poveda, Marta Calvo, Javier Llorca, José M. Berna.

Factores pre y perioperatorios determinantes de la mortalidad precoz en pacientes mayores de 75 años sometidos a circulación extracorp, 2000

Ximena Palacios Ramos, Jorge Alberto Castro, Rafael Meza Jiménez, Juan Camilo Jaramillo, Álvaro Quintero Ossa, Transfusiones en cirugía cardíaca Parte I, Rev. Colomb. anestesiol. vol.35 no.3 Bogotá July/Sep. 2007

Varios autores, Fisiopatología de la Circulación Extracorpórea, 2009, disponible en: http://tratado.uninet.edu/c011502.html

 

The authors who publish in this journal accept the following conditions:

1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.

2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.